Follow us...

 

Search News Archives

Special Offers and Promotions

 

 

News Channels

Lab News

 

View Channel

New Laboratory Products

 

View Channel

Microscopy | Image Analysis

 

View Channel

Separation Science

 

View Channel

Research & Case Studies

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Brochures & Literature

 

View Channel

 

 

Conferences | Events
Amzell B.V.

Amzell B.V.

Amzell B.V.

Products

Contact Amzell B.V.


If you have not logged into the website then please enter your details below.

All articles from Amzell B.V.

  AMZELL to initiate FDA-approved Phase 3 trial of innovative injectable treatment for infantile epileptic disease

Specialist development pharmaceutical company AMZELL B.V has concluded discussions with the FDA ahead of initiating a Phase 3 trial of its new treatment for infantile epileptic disease, AMZ002.

 

 

 

Media Partner